Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

P&G/Aventis Actonel Is Priced At 10% Discount To Merck Fosamax

Executive Summary

Procter & Gamble and marketing partner Aventis will set the price of its Actonel dose for osteoporosis at a discount to Merck's Fosamax.

You may also be interested in...



Merck Fosamax 40 mg Distribution Plan Leaves Room For Once-Weekly Agent

Merck's exclusive distribution program for patients receiving Fosamax 40 mg tablets for Paget's disease will give the company pricing flexibility when a once-weekly 35 mg formulation is approved for prevention of osteoporosis.

Merck Fosamax 40 mg Distribution Plan Leaves Room For Once-Weekly Agent

Merck's exclusive distribution program for patients receiving Fosamax 40 mg tablets for Paget's disease will give the company pricing flexibility when a once-weekly 35 mg formulation is approved for prevention of osteoporosis.

Merck Zocor U.S. Sales Headed Past $3 Bil.: Company Sees 20% Growth

U.S. sales of Zocor appear on track to top $3 bil. in 2000 based on projections of 20% growth for the full year.

UsernamePublicRestriction

Register

LL1133990

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel